Previous 10 | Next 10 |
FDA Type C meeting minutes provide clarity on the Phase 2/3 study design for RAD011 505(b)(2) regulatory strategy: acceptable approach upon completion of PK & food effect studies Based on results, a single well controlled study could serve as the basis for marketing approval...
Radius Health (RDUS) has recently received the written meeting minutes from a June Type C meeting held with the FDA regarding RAD011, a synthetic cannabidiol oral solution, for the treatment of Prader-Willi Syndrome ((PWS)). The main highlights from the FDA meeting minutes are: Results depend...
FDA Type C meeting minutes provide clarity on the Phase 2/3 study design for RAD011 505(b)(2) regulatory strategy: acceptable approach upon completion of PK & food effect studies Based on results, a single well controlled study could serve as the basis for marketing approval...
BOSTON, July 20, 2021 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS) announced today that it will release its second quarter financial results on Thursday, August 5, 2021. The Company will host a conference call and live audio webcast at 8:30 a.m. ET that day to discuss the results ...
Image source: The Motley Fool. Radius Health (NASDAQ: RDUS) Q1 2021 Earnings Call May 07, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Radius Health (RDUS) Q1 2021 Earnings Call Transcript
The following slide deck was published by Radius Health, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Radius Health, Inc. 2021 Q1 - Results - Earnings Call Presentation
Radius Health, Inc. (RDUS) Q1 2021 Earnings Conference Call May 7, 2021 8:30 AM ET Company Participants Ethan Holdaway - Head of IR Kelly Martin - President and Chief Executive Officer Jim Chopas - Finance and Accounting Sal Grausso - Chief Commercial Officer Chhaya Shah - Chief Business Offi...
Radius Health (RDUS): Q1 Non-GAAP EPS of -$0.18 misses by $0.02; GAAP EPS of -$0.34 beats by $0.07.Revenue of $56.26M (+17.4% Y/Y) misses by $4.12M.Press Release For further details see: Radius Health EPS misses by $0.02, misses on revenue
Total net revenue: $56 million vs. $48 million in Q1, 2020, +17% year-over-year TYMLOS ® U.S. product net revenue: $45 million vs. $48 million in Q1, 2020, -6% year-over-year Significant operating leverage improvement: Q1, 2021 adjusted EBITDA: ($5) million vs. ($26...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The year has not been kind to cannabis producer Sundial Growers (NASDAQ: SNDL ). After an amazing but volatile 2020, SNDL stock is down 25% in the last month. Source: Shutterstock It seems the Reddit-induced r...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 10:10:00 ET July 19, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech, Cleantech Sectors. The newest biotech companies are involved in blood disorder treat...
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 54.4% to $0.4264 on volume of 158,036,142 shares Versus Systems Inc. (VS) rose 73.5% to $2.29 on volume of 40,036,424 shares Tesla Inc. (TSLA) rose 5.3% to $220.97 on volume of 32,375,487 shar...
Ferrous, Nonferrous and Finished Steel Sales Volumes Up Sequentially Radius Board Declares Quarterly Dividend PORTLAND, Ore., July 02, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ: RDUS) today reported results for the third quarter of fiscal 2024 ended May 31, 2024. ...